Orange Book product · Generic (ANDA)
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
At a glance
Dec 12, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 12, 2022
3 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Strength
0.2%;EQ 0.5% BASE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
AB
Application
ANDA 215598
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of BRIMONIDINE TARTRATE; TIMOLOL MALEATE
- 2007COMBIGANBrand (NDA)
NDA 021398 · ABBVIE
- 2025BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 219093 · CAPLIN
- 2024BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 217288 · AMNEAL
- 2024BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 216114 · SOMERSET
- 2024BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 214987 · GLENMARK PHARMS LTD
- 2023BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 215230 · ALEMBIC
- 2022BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 091086 · SENTISS
- 2022BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 201949 · REGCON HOLDINGS
- 2022BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 091442 · APOTEX
- 2022BRIMONIDINE TARTRATE AND TIMOLOL MALEATEGeneric (ANDA)
ANDA 091087 · SANDOZ
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
